US Patent Issued to THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY on Oct. 7 for "Injectable hydrogels for controlled release of immunomodulatory compounds" (California Inventors)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,433,959, issued on Oct. 7, was assigned to THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (Stanford, Calif.).

"Injectable hydrogels for controlled release of immunomodulatory compounds" was invented by Gillie A. Roth (Stanford, Calif.), Eric Andrew Appel (Stanford, Calif.), Mark Davis (Stanford, Calif.), Emily C. Gale (Stanford, Calif.) and Santiago Correa (Stanford, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "An immunomodulatory delivery system includes a hydrogel, a first immunomodulatory cargo encapsulated in the cargo, and a second immunomodulatory cargo encapsulated in the hydrogel. The hydrogel includes a polymer non-coval...